Catalyst Wire Dossier Catalyst Wire Dossier

Juvista 250 ng

recombinant human basic fibroblast growth factor (rh-bFGF) · Renovo
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Juvista 250 ng, covering 2010-09-28 to 2010-09-28. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids [Phase 1, Phase 2]

See pricing